Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Breast Diseases | 4 | 2021 | 446 | 1.450 |
Why?
|
Breast | 11 | 2021 | 1819 | 1.420 |
Why?
|
Breast Neoplasms | 24 | 2022 | 20062 | 1.310 |
Why?
|
Body Fluids | 6 | 2013 | 309 | 1.280 |
Why?
|
Labor, Obstetric | 5 | 2016 | 316 | 1.270 |
Why?
|
Premature Birth | 6 | 2020 | 1560 | 0.990 |
Why?
|
Obstetric Labor, Premature | 2 | 2014 | 278 | 0.920 |
Why?
|
Vagina | 6 | 2013 | 779 | 0.880 |
Why?
|
Cervix Uteri | 5 | 2013 | 578 | 0.880 |
Why?
|
Infectious Mononucleosis | 1 | 2022 | 144 | 0.850 |
Why?
|
Mammary Glands, Human | 1 | 2021 | 206 | 0.740 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 2 | 2013 | 298 | 0.730 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2022 | 553 | 0.590 |
Why?
|
Labor Onset | 3 | 2010 | 17 | 0.580 |
Why?
|
Abortion, Threatened | 1 | 2014 | 3 | 0.530 |
Why?
|
Term Birth | 5 | 2014 | 145 | 0.490 |
Why?
|
Interleukin-1alpha | 1 | 2013 | 85 | 0.470 |
Why?
|
Androgens | 1 | 2020 | 1233 | 0.460 |
Why?
|
Testosterone | 2 | 2020 | 2359 | 0.450 |
Why?
|
Blood Cells | 1 | 2014 | 318 | 0.440 |
Why?
|
Tissue Inhibitor of Metalloproteinase-2 | 1 | 2011 | 65 | 0.430 |
Why?
|
Fetal Membranes, Premature Rupture | 2 | 2013 | 134 | 0.430 |
Why?
|
Matrix Metalloproteinase 7 | 1 | 2011 | 60 | 0.430 |
Why?
|
Serum Albumin | 1 | 2014 | 678 | 0.420 |
Why?
|
Cystatin A | 1 | 2010 | 5 | 0.420 |
Why?
|
Tissue Inhibitor of Metalloproteinase-1 | 1 | 2011 | 152 | 0.420 |
Why?
|
Cervix Mucus | 1 | 2010 | 19 | 0.410 |
Why?
|
Cysteine Proteases | 1 | 2010 | 19 | 0.410 |
Why?
|
Receptors, Neurokinin-1 | 1 | 2011 | 126 | 0.390 |
Why?
|
Postmenopause | 2 | 2019 | 2412 | 0.390 |
Why?
|
Diterpenes | 1 | 2011 | 179 | 0.390 |
Why?
|
Capsaicin | 1 | 2011 | 239 | 0.380 |
Why?
|
Substance P | 1 | 2011 | 335 | 0.370 |
Why?
|
Gene Expression | 4 | 2020 | 7954 | 0.360 |
Why?
|
TRPV Cation Channels | 1 | 2011 | 233 | 0.360 |
Why?
|
Cathepsins | 1 | 2010 | 286 | 0.360 |
Why?
|
Pregnancy | 15 | 2020 | 27398 | 0.350 |
Why?
|
Health Surveys | 1 | 2018 | 4036 | 0.330 |
Why?
|
Nurses | 3 | 2022 | 2376 | 0.330 |
Why?
|
Body Mass Index | 4 | 2022 | 12535 | 0.330 |
Why?
|
Interleukin-1beta | 1 | 2013 | 962 | 0.320 |
Why?
|
Receptors, Estrogen | 6 | 2022 | 2167 | 0.300 |
Why?
|
Female | 45 | 2022 | 377204 | 0.270 |
Why?
|
Vaginal Smears | 1 | 2008 | 499 | 0.270 |
Why?
|
Epidemiology | 2 | 2019 | 295 | 0.270 |
Why?
|
Carcinoma, Renal Cell | 1 | 2019 | 2955 | 0.260 |
Why?
|
Databases, Genetic | 4 | 2020 | 1801 | 0.260 |
Why?
|
Pathology, Molecular | 2 | 2019 | 348 | 0.260 |
Why?
|
Urinary Bladder | 1 | 2011 | 1137 | 0.260 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2016 | 3770 | 0.260 |
Why?
|
Adult | 26 | 2022 | 212266 | 0.240 |
Why?
|
Kidney Neoplasms | 1 | 2019 | 4018 | 0.230 |
Why?
|
Receptors, Androgen | 2 | 2019 | 1049 | 0.230 |
Why?
|
Parity | 2 | 2021 | 892 | 0.230 |
Why?
|
Antioxidants | 1 | 2010 | 1670 | 0.220 |
Why?
|
Spinal Cord | 1 | 2011 | 1808 | 0.220 |
Why?
|
Trans-Activators | 3 | 2020 | 3047 | 0.210 |
Why?
|
Gestational Age | 4 | 2020 | 3446 | 0.210 |
Why?
|
Delivery, Obstetric | 1 | 2008 | 907 | 0.200 |
Why?
|
Analysis of Variance | 3 | 2021 | 6501 | 0.200 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2014 | 3947 | 0.200 |
Why?
|
Carcinogens, Environmental | 1 | 2020 | 66 | 0.200 |
Why?
|
Humans | 46 | 2022 | 715777 | 0.190 |
Why?
|
Reproductive History | 1 | 2021 | 209 | 0.190 |
Why?
|
Radon | 1 | 2020 | 66 | 0.190 |
Why?
|
Elasticity | 1 | 2021 | 655 | 0.180 |
Why?
|
Sex Reassignment Surgery | 1 | 2020 | 89 | 0.170 |
Why?
|
Erythrocyte Membrane | 1 | 2020 | 444 | 0.170 |
Why?
|
Risk Factors | 11 | 2022 | 70866 | 0.170 |
Why?
|
Proteomics | 2 | 2013 | 3248 | 0.170 |
Why?
|
Menarche | 1 | 2021 | 492 | 0.170 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2020 | 9004 | 0.160 |
Why?
|
Pregnancy Outcome | 1 | 2008 | 2719 | 0.160 |
Why?
|
Body Size | 1 | 2021 | 467 | 0.160 |
Why?
|
Gene Expression Profiling | 4 | 2019 | 9504 | 0.160 |
Why?
|
Mammary Neoplasms, Animal | 1 | 2018 | 136 | 0.160 |
Why?
|
Automation | 1 | 2019 | 589 | 0.150 |
Why?
|
Predictive Value of Tests | 5 | 2021 | 15199 | 0.150 |
Why?
|
RNA, Messenger | 3 | 2020 | 13213 | 0.150 |
Why?
|
Mammary Glands, Animal | 1 | 2018 | 275 | 0.150 |
Why?
|
Gene Fusion | 1 | 2019 | 371 | 0.150 |
Why?
|
Middle Aged | 16 | 2021 | 214639 | 0.150 |
Why?
|
Risk Assessment | 5 | 2021 | 23464 | 0.140 |
Why?
|
Herpesvirus 4, Human | 1 | 2022 | 1248 | 0.140 |
Why?
|
Gene Expression Regulation | 1 | 2014 | 12305 | 0.140 |
Why?
|
Neoplasms, Hormone-Dependent | 1 | 2018 | 412 | 0.140 |
Why?
|
Alcohol Drinking | 2 | 2020 | 3899 | 0.140 |
Why?
|
Cystadenocarcinoma, Serous | 1 | 2019 | 469 | 0.140 |
Why?
|
Western Australia | 1 | 2014 | 42 | 0.140 |
Why?
|
Genomics | 3 | 2022 | 5342 | 0.130 |
Why?
|
Proteins | 1 | 2010 | 6070 | 0.130 |
Why?
|
Case-Control Studies | 7 | 2021 | 21797 | 0.130 |
Why?
|
Adiposity | 2 | 2021 | 1757 | 0.130 |
Why?
|
Kaplan-Meier Estimate | 3 | 2019 | 6722 | 0.120 |
Why?
|
Body Height | 1 | 2020 | 1609 | 0.120 |
Why?
|
Genes, Reporter | 1 | 2018 | 1603 | 0.120 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 1 | 2021 | 915 | 0.120 |
Why?
|
Reproducibility of Results | 4 | 2021 | 19537 | 0.120 |
Why?
|
Menopause | 1 | 2021 | 1535 | 0.120 |
Why?
|
Fatty Acids | 1 | 2020 | 1746 | 0.110 |
Why?
|
Area Under Curve | 1 | 2016 | 1687 | 0.110 |
Why?
|
Disease Susceptibility | 1 | 2018 | 1780 | 0.110 |
Why?
|
Unsafe Sex | 1 | 2013 | 228 | 0.100 |
Why?
|
Demography | 1 | 2016 | 1625 | 0.100 |
Why?
|
DNA Copy Number Variations | 1 | 2020 | 1894 | 0.100 |
Why?
|
Estradiol | 1 | 2018 | 1978 | 0.100 |
Why?
|
Inflammation Mediators | 1 | 2020 | 1939 | 0.100 |
Why?
|
Proteome | 2 | 2013 | 1761 | 0.100 |
Why?
|
Time Factors | 5 | 2014 | 40875 | 0.100 |
Why?
|
Fibronectins | 1 | 2014 | 720 | 0.100 |
Why?
|
Prognosis | 6 | 2020 | 29005 | 0.100 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2019 | 1536 | 0.100 |
Why?
|
Amniotic Fluid | 1 | 2011 | 361 | 0.090 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2020 | 4040 | 0.090 |
Why?
|
Signal Transduction | 1 | 2013 | 23729 | 0.090 |
Why?
|
Computational Biology | 2 | 2020 | 3571 | 0.090 |
Why?
|
Thioredoxins | 1 | 2010 | 210 | 0.090 |
Why?
|
Environmental Exposure | 2 | 2020 | 4057 | 0.090 |
Why?
|
Sacrum | 1 | 2011 | 301 | 0.090 |
Why?
|
Phthalazines | 2 | 2022 | 357 | 0.090 |
Why?
|
High-Throughput Screening Assays | 1 | 2014 | 933 | 0.090 |
Why?
|
Statistics, Nonparametric | 1 | 2014 | 2950 | 0.080 |
Why?
|
Neoplasm Invasiveness | 1 | 2016 | 3681 | 0.080 |
Why?
|
Risk | 1 | 2021 | 9801 | 0.080 |
Why?
|
Infant, Small for Gestational Age | 1 | 2011 | 437 | 0.080 |
Why?
|
Superoxide Dismutase | 1 | 2010 | 599 | 0.080 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2021 | 3413 | 0.080 |
Why?
|
Labor, Induced | 1 | 2008 | 134 | 0.080 |
Why?
|
Air Pollution | 1 | 2020 | 2047 | 0.080 |
Why?
|
Mass Spectrometry | 1 | 2014 | 2222 | 0.080 |
Why?
|
Rats, Wistar | 1 | 2011 | 1980 | 0.080 |
Why?
|
Protease Inhibitors | 1 | 2010 | 784 | 0.080 |
Why?
|
Air Pollutants | 1 | 2020 | 2632 | 0.070 |
Why?
|
Logistic Models | 1 | 2022 | 13618 | 0.070 |
Why?
|
Vitamin D | 1 | 2020 | 3193 | 0.070 |
Why?
|
Models, Genetic | 1 | 2016 | 3516 | 0.070 |
Why?
|
Aged | 5 | 2021 | 162448 | 0.070 |
Why?
|
Cohort Studies | 3 | 2021 | 40029 | 0.070 |
Why?
|
Maternal Age | 1 | 2008 | 791 | 0.070 |
Why?
|
Receptors, Progesterone | 2 | 2020 | 1118 | 0.070 |
Why?
|
Nerve Tissue Proteins | 1 | 2018 | 4561 | 0.070 |
Why?
|
Oxidation-Reduction | 1 | 2010 | 2299 | 0.070 |
Why?
|
MicroRNAs | 1 | 2020 | 3637 | 0.060 |
Why?
|
Infant, Newborn | 4 | 2020 | 24798 | 0.060 |
Why?
|
Phenotype | 2 | 2022 | 16311 | 0.060 |
Why?
|
Genome-Wide Association Study | 1 | 2022 | 11940 | 0.060 |
Why?
|
Probability | 1 | 2008 | 2487 | 0.060 |
Why?
|
Ovarian Neoplasms | 1 | 2019 | 4751 | 0.060 |
Why?
|
Birth Weight | 1 | 2011 | 1941 | 0.060 |
Why?
|
Longitudinal Studies | 2 | 2020 | 13643 | 0.050 |
Why?
|
Multivariate Analysis | 1 | 2016 | 12480 | 0.050 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2022 | 2939 | 0.050 |
Why?
|
Male | 6 | 2022 | 350324 | 0.050 |
Why?
|
Adolescent | 4 | 2022 | 85155 | 0.050 |
Why?
|
Adenosine Diphosphate | 1 | 2022 | 434 | 0.050 |
Why?
|
Lumbar Vertebrae | 1 | 2011 | 1834 | 0.050 |
Why?
|
Membrane Proteins | 1 | 2018 | 8047 | 0.050 |
Why?
|
Alberta | 1 | 2020 | 53 | 0.050 |
Why?
|
Retrospective Studies | 3 | 2020 | 72443 | 0.050 |
Why?
|
Niacinamide | 1 | 2022 | 428 | 0.050 |
Why?
|
Mastectomy | 2 | 2019 | 1702 | 0.050 |
Why?
|
Obesity | 2 | 2021 | 12248 | 0.050 |
Why?
|
Young Adult | 3 | 2022 | 56226 | 0.050 |
Why?
|
Regression Analysis | 1 | 2010 | 6495 | 0.050 |
Why?
|
Child | 3 | 2022 | 74468 | 0.050 |
Why?
|
Cesarean Section | 1 | 2008 | 1321 | 0.050 |
Why?
|
Tissue Array Analysis | 1 | 2021 | 573 | 0.050 |
Why?
|
Oxidative Stress | 1 | 2010 | 3129 | 0.040 |
Why?
|
Keratin-8 | 1 | 2018 | 11 | 0.040 |
Why?
|
Algorithms | 1 | 2019 | 13758 | 0.040 |
Why?
|
Estrogen Antagonists | 1 | 2019 | 149 | 0.040 |
Why?
|
Keratin-14 | 1 | 2018 | 60 | 0.040 |
Why?
|
Mutation | 2 | 2022 | 29291 | 0.040 |
Why?
|
NAD | 1 | 2022 | 616 | 0.040 |
Why?
|
Biopsy | 2 | 2021 | 6736 | 0.040 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2022 | 901 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2011 | 11201 | 0.040 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2019 | 326 | 0.040 |
Why?
|
Germ Cells | 1 | 2022 | 587 | 0.040 |
Why?
|
Pregnancy Trimester, Third | 1 | 2020 | 572 | 0.040 |
Why?
|
Morpholines | 1 | 2019 | 572 | 0.040 |
Why?
|
PTEN Phosphohydrolase | 1 | 2022 | 1161 | 0.040 |
Why?
|
Epithelium | 1 | 2021 | 1721 | 0.040 |
Why?
|
Pathology | 1 | 2019 | 270 | 0.040 |
Why?
|
Aminopyridines | 1 | 2019 | 541 | 0.040 |
Why?
|
Cytokines | 1 | 2011 | 7190 | 0.040 |
Why?
|
Anthropometry | 1 | 2020 | 1370 | 0.040 |
Why?
|
Stromal Cells | 1 | 2021 | 1338 | 0.030 |
Why?
|
Aromatase Inhibitors | 1 | 2019 | 499 | 0.030 |
Why?
|
Reactive Oxygen Species | 1 | 2022 | 2099 | 0.030 |
Why?
|
Microarray Analysis | 1 | 2017 | 778 | 0.030 |
Why?
|
Rats | 1 | 2011 | 24860 | 0.030 |
Why?
|
Tamoxifen | 1 | 2019 | 992 | 0.030 |
Why?
|
Cell Line, Tumor | 2 | 2022 | 16736 | 0.030 |
Why?
|
Mitosis | 1 | 2019 | 1248 | 0.030 |
Why?
|
Estrogen Receptor alpha | 1 | 2017 | 579 | 0.030 |
Why?
|
Validation Studies as Topic | 1 | 2013 | 169 | 0.030 |
Why?
|
Sensitivity and Specificity | 1 | 2008 | 14902 | 0.030 |
Why?
|
Forkhead Transcription Factors | 1 | 2019 | 1597 | 0.030 |
Why?
|
Green Fluorescent Proteins | 1 | 2018 | 2185 | 0.030 |
Why?
|
Neoplasms | 2 | 2019 | 20528 | 0.030 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2019 | 8571 | 0.030 |
Why?
|
Prospective Studies | 3 | 2020 | 51315 | 0.030 |
Why?
|
Cross-Sectional Studies | 1 | 2011 | 23438 | 0.030 |
Why?
|
Tumor Microenvironment | 1 | 2022 | 3054 | 0.030 |
Why?
|
Receptor, erbB-2 | 1 | 2020 | 2313 | 0.020 |
Why?
|
Cell Division | 1 | 2018 | 4699 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2019 | 3551 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2021 | 3225 | 0.020 |
Why?
|
Particulate Matter | 1 | 2020 | 2282 | 0.020 |
Why?
|
Piperazines | 1 | 2019 | 2524 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2018 | 6641 | 0.020 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 2008 | 289 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2019 | 3063 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2019 | 7015 | 0.020 |
Why?
|
Specimen Handling | 1 | 2013 | 698 | 0.020 |
Why?
|
Macrophages | 1 | 2022 | 5742 | 0.020 |
Why?
|
Disease Management | 1 | 2018 | 2523 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2018 | 5074 | 0.020 |
Why?
|
Pregnancy Trimester, First | 1 | 2011 | 840 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2018 | 6009 | 0.020 |
Why?
|
Protein Array Analysis | 1 | 2008 | 412 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2018 | 3638 | 0.020 |
Why?
|
Cell Movement | 1 | 2018 | 5397 | 0.020 |
Why?
|
Animals | 3 | 2018 | 169420 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2018 | 9849 | 0.020 |
Why?
|
Diet | 1 | 2022 | 7565 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2019 | 12456 | 0.020 |
Why?
|
Boston | 1 | 2017 | 9377 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2019 | 10620 | 0.010 |
Why?
|
Age Factors | 1 | 2020 | 18784 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2020 | 8896 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 11236 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2020 | 39300 | 0.010 |
Why?
|
Child, Preschool | 1 | 2020 | 41198 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2008 | 14161 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2008 | 18591 | 0.010 |
Why?
|
Mice | 1 | 2018 | 80375 | 0.010 |
Why?
|